Eywa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EYWA, and what generic and branded alternatives to EYWA drugs are available?
EYWA has sixteen approved drugs.
Drugs and US Patents for Eywa
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eywa Pharma | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 211556-001 | Oct 18, 2019 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Eywa Pharma | ALOSETRON HYDROCHLORIDE | alosetron hydrochloride | TABLET;ORAL | 211621-001 | Sep 16, 2019 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Eywa | OXYBUTYNIN CHLORIDE | oxybutynin chloride | TABLET;ORAL | 211062-001 | Feb 6, 2019 | BX | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Eywa | POTASSIUM CITRATE | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 214426-002 | Feb 19, 2021 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Eywa | LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 207863-002 | Feb 4, 2019 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Eywa | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | SOLUTION;ORAL | 210139-002 | Oct 3, 2018 | AA | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.